- Home
- ICU vs CSCI Comparison
ICU vs CSCI Comparison
Compare ICU & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICU
- CSCI
- Stock Information
- Founded
- ICU 2018
- CSCI 1990
- Country
- ICU United States
- CSCI Canada
- Employees
- ICU N/A
- CSCI N/A
- Industry
- ICU Biotechnology: Pharmaceutical Preparations
- CSCI
- Sector
- ICU Health Care
- CSCI
- Exchange
- ICU Nasdaq
- CSCI NYSE
- Market Cap
- ICU 10.3M
- CSCI 11.1M
- IPO Year
- ICU N/A
- CSCI 1996
- Fundamental
- Price
- ICU $2.00
- CSCI $2.66
- Analyst Decision
- ICU
- CSCI
- Analyst Count
- ICU 0
- CSCI 0
- Target Price
- ICU N/A
- CSCI N/A
- AVG Volume (30 Days)
- ICU 24.8K
- CSCI 4.7K
- Earning Date
- ICU 11-13-2024
- CSCI 11-12-2024
- Dividend Yield
- ICU N/A
- CSCI N/A
- EPS Growth
- ICU N/A
- CSCI N/A
- EPS
- ICU N/A
- CSCI N/A
- Revenue
- ICU $68,000.00
- CSCI $4,834,000.00
- Revenue This Year
- ICU N/A
- CSCI N/A
- Revenue Next Year
- ICU $344.44
- CSCI N/A
- P/E Ratio
- ICU N/A
- CSCI N/A
- Revenue Growth
- ICU N/A
- CSCI N/A
- 52 Week Low
- ICU $1.70
- CSCI $2.62
- 52 Week High
- ICU $42.93
- CSCI $11.10
- Technical
- Relative Strength Index (RSI)
- ICU 39.05
- CSCI N/A
- Support Level
- ICU $1.70
- CSCI N/A
- Resistance Level
- ICU $2.04
- CSCI N/A
- Average True Range (ATR)
- ICU 0.19
- CSCI 0.00
- MACD
- ICU 0.01
- CSCI 0.00
- Stochastic Oscillator
- ICU 33.33
- CSCI 0.00
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.